+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria



Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria



Microbial Drug Resistance 23(4): 497-499



QepA is a plasmid-mediated quinolone resistance determinant of low prevalence described worldwide, mainly in Enterobacteriaceae. This study describes, for the first time in Algeria, two clonally related, QepA-producing Escherichia coli clinical isolates positive for CTX-M-15. The clonal spread of these multidrug-resistant isolates is a major public health concern.

(PDF emailed within 0-6 h: $19.90)

Accession: 058448990

Download citation: RISBibTeXText

PMID: 27736309

DOI: 10.1089/mdr.2016.0135


Related references

Occurrence of plasmid-mediated quinolone resistance and virulence genes in avian Escherichia coli isolates from Algeria. Journal of Infection in Developing Countries 11(2): 143-151, 2017

Plasmid-mediated quinolone resistance determinant qepA1 and extended-spectrum β-lactamase gene blaCTX-M-14 co-located on the same plasmid in two Escherichia coli strains from China. Journal of Medical Microbiology 61(Pt 4): 603-605, 2012

Plasmid-mediated fluoroquinolone efflux pump gene, qepA, in Escherichia coli clinical isolates in Korea. Diagnostic Microbiology and Infectious Disease 65(3): 335-338, 2010

Role of topoisomerase mutations, plasmid mediated resistance (qnr) and acrAB efflux pump in fluoroquinolone resistant clinical isolates of avian Escherichia coli. Molecular Genetics, Microbiology and Virology 32(1): 49-54, 2017

Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals. Antimicrobial Agents and ChemoTherapy 58(9): 5638-5639, 2015

Detection of the plasmid-mediated mcr-1 gene in clinical KPC-2-producing Escherichia coli isolates in Brazil. International Journal of Antimicrobial Agents 50(2): 282-284, 2017

First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. International Journal of Antimicrobial Agents 48(6): 760-761, 2016

Detection of the plasmid-borne quinolone resistance determinant qepA1 in a CTX-M-15-producing Escherichia coli strain from Mexico. Journal of Antimicrobial ChemoTherapy 65(1): 169-171, 2010

Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian Journal of Medical Microbiology 30(4): 442-447, 2013

Prevalence of Plasmid-Mediated Fosfomycin Resistance Gene fosA3 Among CTX-M-Producing Escherichia coli Isolates from Chickens in China. Foodborne Pathogens and Disease 14(4): 210-218, 2017

A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China. Foodborne Pathogens and Disease 7(2): 207-215, 2010

The prevalence of plasmid-mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC-producing Escherichia coli from Chinese pediatric patients. Microbiology and Immunology 54(3): 123-128, 2010

Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA. Journal of Antimicrobial ChemoTherapy 68(5): 1019-1024, 2013

In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase. Antimicrobial Agents and ChemoTherapy 50(4): 1525-1527, 2006

Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrobial Agents and ChemoTherapy 54(7): 3061-3064, 2010